Quick Answer
LeonaBio, Inc. reported Research And Development Expense of $17.50 million for the year ending 2025.
- LeonaBio, Inc. showed a decrease of -75.2% in Research And Development Expense from 2024 to 2025.
- This data is from LeonaBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), LeonaBio, Inc.'s Research And Development Expense has grown by 361.4%.
- Historical annual values: Fiscal year 2025: $17.50 million | Fiscal year 2024: $70.68 million | Fiscal year 2023: $93.79 million | Fiscal year 2022: $61.46 million | Fiscal year 2021: $42.79 million | Fiscal year 2020: $13.29 million | Fiscal year 2019: $3.79 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: